Clinical Trials

NCT07022418 | NOT_YET_RECRUITING | PHASE2
120 Participants

Formoterol in Diabetes

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2026-01-31
Completion: 2026-12-31
Conditions
Diabetic Nephropathies Diabetic Kidney Disease
Interventions
DRUG
No Results Yet
NCT07018323 | RECRUITING | PHASE2
210 Participants

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-19
Completion: 2027-05-31
Conditions
Graves' Disease
Interventions
DRUG
No Results Yet
NCT07016321 | NOT_YET_RECRUITING | PHASE2/PHASE3
600 Participants

Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-12-01
Completion: 2029-03-01
Conditions
Dengue
Interventions
DRUG
No Results Yet
NCT07015905 | RECRUITING | PHASE3
2000 Participants

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-25
Completion: 2027-02-20
Conditions
Venous Thromboembolism (VTE)
Interventions
DRUG
No Results Yet
NCT07011706 | RECRUITING | PHASE2
96 Participants

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-05-30
Completion: 2026-08-31
Conditions
Atopic Dermatitis Atopic Dermatitis AD Eczema
Interventions
DRUG
No Results Yet
NCT07003919 | RECRUITING | PHASE3
480 Participants

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-24
Completion: 2026-11-30
Conditions
Allergy Peanut Allergy
Interventions
COMBINATION_PRODUCT
No Results Yet
NCT06997497 | RECRUITING | PHASE3
477 Participants

A Clinical Study of MK-1084 With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-07-16
Completion: 2029-08-27
Conditions
Colon Adenocarcinoma Rectal Adenocarcinoma
Interventions
DRUG BIOLOGICAL
No Results Yet
NCT06997029 | RECRUITING | PHASE1
234 Participants

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-08-01
Completion: 2028-12-14
Conditions
Advanced Solid Tumor Advanced Breast Cancer Advanced Ovarian Cancer
Interventions
DRUG
No Results Yet
NCT06995898 | RECRUITING | NA
24000 Participants

The Vanguard Study: Testing a New Way to Screen for Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-16
Completion: 2027-12-31
Conditions
Bladder Carcinoma Breast Carcinoma Colorectal Carcinoma Esophageal Carcinoma Gastric Carcinoma Liver Carcinoma Lung Carcinoma Malignant Solid Neoplasm Ovarian Carcinoma Pancreatic Carcinoma Prostate Carcinoma
Interventions
PROCEDURE DEVICE OTHER
No Results Yet
NCT06995053 | RECRUITING | NA
80 Participants

Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-27
Completion: 2035-09-01
Conditions
Localized Prostate Adenocarcinoma Stage I Prostate Cancer AJCC v8 Stage II Prostate Cancer AJCC v8 Stage III Prostate Cancer AJCC v8
Interventions
PROCEDURE RADIATION OTHER
No Results Yet
NCT06989112 | RECRUITING | PHASE3
600 Participants

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-03-27
Completion: 2029-01-19
Conditions
Endometrial Cancer
Interventions
DRUG
No Results Yet
NCT06988202 | NOT_YET_RECRUITING | NA
630 Participants

Comparative Effectiveness of Different Techniques for Repeat Ablation of Atrial Fibrillation

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-11-30
Completion: 2030-01-01
Conditions
Atrial Fibrillation (AF)
Interventions
PROCEDURE
No Results Yet
NCT06985784 | RECRUITING | NA
40 Participants

Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and Caregivers

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-25
Completion: 2027-11-09
Conditions
Head and Neck Carcinoma
Interventions
OTHER
No Results Yet
NCT06982443 | RECRUITING | NA
120 Participants

Wellness, Alcohol, Vitals, and Emotions

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-10-01
Completion: 2027-12-31
Conditions
Alcohol Use
Interventions
BEHAVIORAL
No Results Yet
NCT06979596 | RECRUITING | PHASE2
250 Participants

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-08-11
Completion: 2027-11-04
Conditions
Malignant Neoplasm
Interventions
DRUG
No Results Yet
NCT06976268 | RECRUITING | PHASE2/PHASE3
550 Participants

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-05-28
Completion: 2027-08-31
Conditions
Parkinson Disease
Interventions
DRUG
No Results Yet
NCT06973291 | RECRUITING | PHASE3
600 Participants

A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-07-09
Completion: 2026-06-05
Conditions
Plaque Psoriasis
Interventions
DRUG
No Results Yet
NCT06973187 | RECRUITING | PHASE3
500 Participants

A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-09-04
Completion: 2028-04-17
Conditions
Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma
Interventions
DRUG
No Results Yet
NCT06972446 | RECRUITING | PHASE2
180 Participants

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-20
Completion: 2027-02-28
Conditions
Rheumatoid Arthritis
Interventions
DRUG
No Results Yet
NCT06970665 | RECRUITING | PHASE4
20 Participants

A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-07-08
Completion: 2027-06-30
Conditions
Geographic Atrophy Age-Related Macular Degeneration
Interventions
DRUG
No Results Yet
NCT06968494 | RECRUITING | NA
20 Participants

Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-05
Completion: 2027-04-30
Conditions
Erectile Dysfunction Following Radical Prostatectomy
Interventions
DEVICE
No Results Yet
NCT06967129 | COMPLETED | NA
281 Participants

Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-04-25
Completion: 2025-07-14
Conditions
Astigmatism
Interventions
DEVICE
No Results Yet
NCT06966713 | RECRUITING
120 Participants

Predict Severe Traumatic Brain Injury

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2023-02-20
Completion: 2026-07-13
Conditions
Traumatic Brain Injury
No Results Yet
NCT06966700 | RECRUITING | PHASE3
2400 Participants

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-30
Completion: 2033-03-23
Conditions
Breast Neoplasms Triple Negative Breast Neoplasms HR Low-Positive/HER2-Negative Breast Neoplasms
Interventions
BIOLOGICAL DRUG
No Results Yet
NCT06965075 | COMPLETED | NA
15 Participants

The SCULPT-Job Cohort Study

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2023-12-14
Completion: 2025-06-30
Conditions
Weight Maintenance Weight Loss Stress, Psychological Job Stress Diabetes Prevention Obesity Cardiovascular Risk Factor Cardiovascular Diseases
Interventions
BEHAVIORAL
No Results Yet
NCT06965010 | ENROLLING_BY_INVITATION | NA
3650 Participants

Measurement Based Care in Opioid Treatment Programs

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-10-01
Completion: 2027-11-01
Conditions
Opioid Use Disorder
Interventions
BEHAVIORAL
No Results Yet
NCT06959537 | RECRUITING | PHASE1
24 Participants

A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) + Retifanlimab (R) in Treating Metastatic Triple Negative Breast Cancer (TNBC)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-08-13
Completion: 2027-01-31
Conditions
Breast Cancer
Interventions
DRUG
No Results Yet
NCT06959225 | RECRUITING | PHASE3
400 Participants

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-23
Completion: 2026-10-09
Conditions
Hidradenitis Suppurativa
Interventions
DRUG
No Results Yet
NCT06958328 | RECRUITING | PHASE3
356 Participants

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-08-21
Completion: 2030-10-21
Conditions
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma Stage II Pancreatic Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8
Interventions
PROCEDURE DRUG RADIATION OTHER
No Results Yet
NCT06958211 | RECRUITING | PHASE3
450 Participants

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-12
Completion: 2026-10-09
Conditions
Hidradenitis Suppurativa
Interventions
DRUG
No Results Yet
NCT06953583 | RECRUITING | PHASE3
255 Participants

A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-09
Completion: 2027-11-16
Conditions
Friedreich Ataxia
Interventions
DRUG
No Results Yet
NCT06952803 | RECRUITING | PHASE3
700 Participants

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-08-06
Completion: 2033-03-31
Conditions
Prostate Cancer
Interventions
DRUG
No Results Yet
NCT06952504 | RECRUITING | PHASE3
1123 Participants

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-05-22
Completion: 2032-05-24
Conditions
Endometrial Cancer
Interventions
BIOLOGICAL DRUG
No Results Yet
NCT06949800 | NOT_YET_RECRUITING | PHASE2
90 Participants

PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-12-01
Completion: 2026-10-31
Conditions
HSIL, High Grade Squamous Intraepithelial Lesion HPV-Related Squamous Cell Carcinoma Anal HSIL
Interventions
DRUG PROCEDURE
No Results Yet
NCT06943872 | RECRUITING | PHASE3
630 Participants

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-06-11
Completion: 2029-09-30
Conditions
Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma
Interventions
DRUG
No Results Yet
NCT06943859 | RECRUITING | PHASE2
50 Participants

Ketamine for Opioid Use Disorder

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-11-30
Completion: 2028-08-31
Conditions
Opioid Use Disorder
Interventions
DRUG
No Results Yet
NCT06940271 | RECRUITING | NA
25 Participants

Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-08-14
Completion: 2030-07-30
Conditions
Localized Prostate Carcinoma Stage I Prostate Cancer AJCC v8 Stage II Prostate Cancer AJCC v8 Stage III Prostate Cancer AJCC v8
Interventions
PROCEDURE OTHER
No Results Yet
NCT06939478 | RECRUITING
110 Participants

AI Powered Mapping Technology for Identifying Arrhythmias

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2025-08-27
Completion: 2025-12-31
Conditions
Arrhythmias, Cardiac
Interventions
DEVICE
No Results Yet
NCT06935357 | RECRUITING | PHASE3
454 Participants

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-05-08
Completion: 2027-05-31
Conditions
Immunoglobulin A Nephropathy (IgAN)
Interventions
DRUG
No Results Yet
NCT06935097 | ENROLLING_BY_INVITATION | NA
25 Participants

Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2025-10-24
Completion: 2029-03-31
Conditions
Prostate Cancer
Interventions
BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page · Total 557286 trials